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Proteins can occasionally behave aberrantly within the cell and cause a variety of physiological 
issues. Multiple pathways exist that resolve this problem and allow the cell to continue normal 
protein production. Endoplasmic Reticulum (ER)-Associated Degradation (ERAD) and Inner 
Nuclear Membrane-Associated Degradation (INMAD) are pathways that remove these 
misfolded and otherwise aberrant proteins. Dysfunction in either system may result in numerous 
pathologies, including those relating to cholesterol homeostasis and neurodegeneration. When 
misfolded proteins accumulate in the endoplasmic reticulum (ER stress), some of these 
misfolded proteins are unable to be removed. We hypothesize that there are proteins that work in 
both pathways (ER stress recovery and ERAD/INMAD), and when present in excess, can restore 
degradation. Using the model organism Saccharomyces cerevisiae, proteins involved these 
pathways will be ~tudied. First, a plasmid harboring the gene for a known ERAD substrate that 
engages the translocon was created. Second, four unique yeast strains were created, each 
harboring a combination of gene knockouts that encode enzymes involved in both ERAD and 
INMAD degradation pathways. Understanding these protein quality mechanisms may facilitate 
the development of improved therapeutics for human disease. 
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Process Analysis 
This project has revealed more about myself than I had expected. When I first began 
working in Dr. Rubenstein' s lab two years ago, it was quite an unfamiliar environment. The only 
lab experience I had was from the lab sections of my major classes, which offered a regimented 
and formulaic dynamic. Protocol within the weekly experiments was clearly defined by the 
instructor, and my actions were always closely watched to ensure I didn't make any errors. 
Extracurricular research was a stark contrast to this system. Each week, my PI outlined what 
needed to be done in each step, and then I was on my own to complete each objective. Even 
though I may have failed to get adequate results a few times, this process eventually revealed to 
me the resiliency that is needed to be successful in the field of cellular and molecular biology. 
Failure allowed me to see what I did wrong, and create a plan to ensure it didn't happen again. It 
wasn't failure in the sense that we as students often believe, but an opportunity to learn. It not 
only cultivated resiliency, but determination and critical thinking as well. 
This project is full of blood, sweat and tears, and I am couldn't be more proud of the final 
outcome. I have learned so much about tlie field of cellular and molecular biology, as well as 
how to write professionally. The character qualities that have been reinforced throughout this 
experience will follow me as I enter medical school in the Fall, and beyond. I will have to apply 
that same determination as before, and refuse to accept perceived failure. 
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Introduction 
Protein quality control within the eukaryotic cell is dependent upon the ubiquitin 
proteasome system, or UPS [1]. A number of different enzymes work in conjunction to target 
and destroy damaged, misfolded, or aberrant proteins. Before degradation can occur, A TP 
hydrolysis must fuel the covalent linkage ofubiquitin molecules to E1 ubiquitin-activating 
enzymes. The ubiquitin molecules can be tr_ansferred to one or more E2 ubiquitin-conjugating 
enzymes, which then bind to E3 ubiquitin ligases. The E3s then bind to substrates (misfolded, 
damaged, or otherwise aberrant proteins), and mediate the transfer of ubiquitin from E2s onto 
targeted proteins. After polyubiquitylation, these aberrant proteins can then be degraded by a 
protease located in the cytosol, known as the proteasome [ 1-3]. 
Endoplasmic Reticulum (ER)-Associated Degradation (ERAD) is the targeting ofER-
resident misfolded or otherwise aberrant proteins for degradation [1, 4, 5]. Depending on where 
the degradation signal (the degron) lies within the aberrant protein, ERAD-C, ERAD-M, ERAD-
L, ERAD-Tor Inner Nuclear Membrane-Associated Degradation (INMAD) could be invoked to 
remove it (Figure 1 ). Degrons that lie within the cytosolic portion of a protein undergo ERAD-C 
(cytosol), which is mediated by the E3 ubiquitin ligase Doa10. These proteins can be either 
transmembrane with cytosolic portions or soluble cytosolic proteins that come into contact with 
the ER. If the degradation signal lies within a transmembrane segment of a protein, ERAD-M 
(membrane) will be initiated along with the E3 Hrd1 to remove the protein. Proteins with 
degrons within the lumen are also Hrd1 substrates and utilize the ERAD-L (lumen) pathway for 
removal [ 4]. 
As proteins enter the endoplasmic reticulum for processing or secretion from the cell, 
they must first pass through a protein channel known as the translocon [ 6]. Proteins that become 
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stuck within this charmel must be removed in order to maintain proper homeostasis. Rubenstein 
et al. discovered that the ubiquitin ligase that targets these substrates for ubiquitylation and 
subsequent degradation via the proteasome is Hrd1 via the ERAD-T (translocon) pathway [7]. 
When a protein blocks this charmel, translocation of other proteins into the ER may become 
hindered. It is not until Hrd1 catalyzes the polyubiquitylation of the aberrant protein and the 
protein is subsequently degraded by the proteasome that functional translocation can be 
reestablished. There are numerous associated proteins that work in the ERAD-C, ERAD-L, and 
ERAD-M pathways alongside Doa1 0 and Hrdl; however, the proteins that function with Hrdl in 
the ERAD-T pathway remain under study [6, 7, 8]. At least one medically relevant protein, 
apolipoprotein B (apoB) persistently engages the translocon in humans. ApoB is a component of 
low-density lipoproteins (LDLs, or "bad cholesterol") within the human circulatory system. 
ApoB partially traverses the translocon and awaits lipid binding to its ER luminally exposed 
portion. Following lipid binding, apoB passes completely through the translocon and assembles 
with the bound lipids into an LDL particle. Iflipid binding is prevented, Hrdl recognizes and 
ubiquitylates apoB, targeting it for degradation. Further understanding of this pathway could lead 
to improved treatment of hypercholesterolemia. 
Aberrant proteins within the inner nuclear membrane are degraded by a pathway known 
as INMAD [9]. A complex of integral membrane proteins catalyze the ubiquitylation of these 
proteins, which allows for their degradation by the proteasome. Three subunits (Asi 1, Asi2, and 
Asi3) form a holoenzyme called the Asi complex that acts as the E3 ubiquitin ligase in this 
pathway. This pathway, like the other ERAD pathways, promotes homeostasis within the cell by 
promoting the removal of damaged or misfolded proteins [9, 10]. Little is known about whether 
or how the ERAD and INMAD E3 ubiquitin ligases work in conjunction with one another. 
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Systematic combinations ofE3 gene knockouts (created in this study) will provide a way to 
study the function and interactions of the Asi complex within the cell. 
Protein quality control mediated by the UPS is critical for cell survival. ERAD or UPS 
dysfunction is a common etiology of many human diseases [16, 17]. Alzheimer's disease and 
Parkinson's disease have been proposed to be the result of malfunction of the ubiquitin 
proteasome system at the ER membrane and the subsequent accumulation of aberrant proteins. 
This system can also be a future therapeutic target for conditions like cystic fibrosis. A single 
amino acid mutation causes the creation of a near-functional protein; however, the ERAD 
pathway catalyzes its degradation. Further, ERAD-T of apoB may be a therapeutic target for 
hypercholesterolemia. Discovery of the proteins that function in these pathways may yield novel 
therapeutic targets for these conditions. 
Protein quality control pathways can be studied in vivo using Saccharomyces cerevisiae, 
or baker' s yeast. S. cerevisiae is an optimal organism for this study due to its extensively mapped 
genome, short doubling time of approximately 90 minutes, and conservation of the UPS and 
ERAD systems with other eukaryotic organisms [1, 4, 14, 15]. Thus, this organism provides an 
excellent model for basic biology relevant to human health and disease. 
The first identified degron that targets a protein for UPS-dependent degradation is Degl , 
the N-terminal.67 amino acids ofthe transcriptional repressor MATa2. MATa2 is a substrate of 
the DoalO-mediated ERAD-C system [4, 11 , 12]. When Degl is artificially linked to an 
otherwise stable soluble cytosolic protein (e.g. green fluorescent protein) or transmembrane 
protein (e.g. Vma12), it causes the fusion protein to be removed via ERAD-C [13]. Sec62, a 
transmembrane protein with similar membrane topology to Vma12, was also expected to be 
converted to a Doa lO substrate when Degl was fused to the cytosolic N-terminal portion of the 
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protein. However, Rubenstein et al. discovered that the Degl-Sec62 protein became a Hrdl 
substrate, following aberrant interaction with the translocon [7]. 
The fusion of Degl to the transmembrane protein Sec62 causes a portion of the protein to 
move into - and likely stall within- the translocon [7; Figure 2]. The Sec62 protein is comprised 
of two transmembrane segments that are likely integrated into the ER membrane via co-
translational translocation. The Degl degron is located on the cytosolic N-terminus of the protein 
and triggers aberrant engagement with the translocon. Hrdl is then recruiteq based on this 
interaction and catalyzes the initiation of ERAD-T [7]. This mechanism is known to be different 
than the Doal 0-dependent degradation of Degl-containing proteins, because a mutation in Degl 
that prevents DoalO-dependent degradation ofERAD-C substrates does not similarly prevent 
Hrdl degradation of the Degl-Sec62 protein [7]. 
A unique plasmid housing the Degl-Sec62 coding sequence in frame with the Ura3 
enzyme (which catalyzes an essential step in the uracil biosynthesis pathway) was created to 
further study the ERAD-T pathway (Sheldon Watts and Eric Rubenstein, unpublished data). The 
gene encoding Degl-Sec62-Ura3 is designed to be amplified by PCR and integrated into the 
yeast genome. To select for yeast cells that possess Degl-Sec62-Ura3 , the natMX4 gene (which 
confers resistance to the antibiotic nourseothricin) was linked to this gene (as a completely 
separate gene) in this study; growth of cells in the presence of nourseothricin would confirm 
presence ofthe DNA encoding Degl-Sec62-Ura3. The Degl-Sec62-Ura3 gene product will then 
allow for selection on the basis of yeast growth in the absence of uracil and help pinpoint genes 
that work in the ERAD-T pathway. Ura3 catalyzes a reaction in the uracil biosynthesis pathway. 
Yeast cells with mutations that impair ERAD-T (i.e. fail to degrade Degl-Sec62-Ura3) will 
selectively grow on media that lacks uracil (Figure 3). The Ura3 protein can also be exploited in 
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a counter-selection growth assay involving the compound 5-Fluoroorotic Acid (5-FOA). In the 
presence of a functional Ura3 protein, 5-FOA is converted to the toxic compound 5-fluorouracil 
(5-FU). Therefore, ifERAD-T is not functioning properly and Degl-Sec62-Ura3 protein is 
stabilized, 5-FU will be created, and the cells will not survive. 
The counter-selection growth assay can be used to identify genes that influence ERAD-T. 
ERAD-T is impaired under conditions of ER stress, which is characterized by elevated levels of 
misfolded proteins in the ER lumen (Figure 3; Bryce Buchanan, Eric Rubenstein, and Mark 
Hochstrasser, unpublished data). It is hypothesized that a protein that functions in ERAD-T may 
also function in the ER stress response. Overexpression of this protein may rescue the ERAD-T 
pathway under ER stress conditions. Using the previously described counter-selection strategy, 
stabilization of Degl-Sec62-Ura3 within the translocon and subsequent creation of 5-FU during 
conditions of ER stress will impair cell survival. A gene that functions in both ERAD-T and ER 
stress response may be identified on the basis of restored cell growth (i.e. restored ERAD-T) 
under ER stress conditions if the gene is overexpressed. 
The importance of protein quality control cannot be understated. Malfunctions in ERAD 
have the potential to cause a variety of harmful etiologies. The plasmid and yeast strains created 
for these studies can be used to investigate these mechanisms. With a better understanding of 
these pathways lies the potential for the development of new therapeutic strategies. 
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Goals 
1. Generate a plasmid encoding a model ERAD-T substrate (Degl-Sec62-Ura3) and a gene 
conferring nourseothricin resistance (natMX4). 
2. Generate yeast strains expressing and lacking all combinations of ERAD and INMAD 
ubiquitin ligases (Doa10, Hrd1, and Asi complex). 
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Materials and Methods 
Creation of plasmid containing Degl-Sec62-Ura3 and natMX4 
The parent plasmids pVJ32 (p414-MET25-Degl-Sec62-Ura3; vector plasmid) and 
pVJ132 (pAG25; insert plasmid) were stored in E. coli cells at -80°C. These E. coli were fust 
streaked for isolation on Luria Broth plates that contained 50 )lg/mL ampicillin, and incubated 
for 24 hours at 3 7°C. An individual colony from each plate was inoculated into 4 ml of liquid 
Luria Broth with ampicillin. The plasmid DNA was then isolated from these inoculates using the 
Promega miniprep kit and protocol. These DNA preparations were then digested with the 
restriction enzyme Eagl overnight at 37°C (5 )lL miniprep DNA, 1 )lL ofEagl, 2.5 )lL lOX 
NEBuffer, and 16.5 )lL water). After digestion, the vector plasmid was incubated with Antarctic 
phosphatase for one hour at 3 7°C (3 )lL of Antarctic phosphatase buffer and 1 )lL Antarctic 
phosphatase were added directly to the vector digest). The digested samples were then separated 
on a 1% agarose gel at 100 volts in T AE (Tris-acetate ethylenediaminetetraacetic acid (EDT A)) 
buffer for approximately 45 minutes. From the gel, a 7673 bp fragment (vector) and 1314 bp 
fragment (insert) were isolated and purified using the Qiagen gel purification kit and protocol. 
The vector and insert fragments were eluted in 30 )lL of elution buffer. The purified fragments 
were then ligated using T4 DNA ligase in lX ligation buffer in 20 )lL ligation reactions, and 
incubated at 23°C overnight. Four ligation reactions were created. The fust reaction included 2 
)lL of insert DNA, 2 )lL of vector DNA, and 1 )lL ofT4 DNA ligase. The second reaction 
included 15 )lL of insert DNA, 2 )lL ofvector DNA, and 1 )lL ofT4 DNA ligase. The third 
reaction included 2 )lL of vector DNA and 1 )lL ofT4 DNA ligase (and no insert DNA). The 
fourth reaction included 2 )lL of vector DNA (and no insert DNA or T4 DNA ligase). The 
ligation reaction products were then transformed into chemically competent E. coli cells by 
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mixing 1 0 11L of the ligation reaction products and 25 11L of cells. These components were then 
placed on ice for approximately 1 hour and 45 minutes, incubated in a 42°C water bath for 30 
seconds, and returned to the ice for two minutes. Next, 1 mL of warm (37°C) Luria Broth was 
added to each tube, which was incubated at 37°C for 30 minutes. The cells were pelleted via 
centrifugation (13,000 x g for 5 minutes) and resuspended in approximately 100 11L of Luria 
Broth. These cells were then spread on Luria Broth plates with ampicillin and incubated 
overnight at 3 7°C. 
The recombinant plasmid DNA of candidate colonies was isolated via the Promega 
mini prep kit and protocol and digested with the restriction enzyme Eagl in NEBuffer 3.1, as 
described above. Digested DNA was analyzed on a 1% agarose gel to screen for the presence of 
both the vector (7673 bp) and insert (1314 bp) fragments . Candidate samples that contained both 
fragments were then screened for orientation of the insert using a high-fidelity version of the 
restriction enzyme Nco! (5 J..!L miniprep DNA, 1 J..!L ofNcoi-HF, 2.5 11L of lOX CutSmart 
Buffer, and 16.5 J..!L of water). The samples were incubated overnight at 37°C and analyzed on 
another 1% agarose gel. If the insert fragment was ligated such that the natMX4 gene and the 
Degl-Sec62-Ura3 gene were oriented in the same direction (i.e. transcribed from the same 
strand), the expected Neal-generated fragments would be 6212, 1461 , and 1324 bp. By contrast, 
if the insert fragment was ligated in the opposite direction ofthe Degl-Sec62-Ura3 gene, the 
expected Neal-generated fragments would be 5790, 1736, 1461 bp. Candidates that displayed 
appropriate banding patterns were stored as glycerol permanent stocks at -80°C by combining 1 
mLof culture with 500 J..!L of 75% glycerol. 
Generation of yeast strains with knockout of ASI3 gene 
In this procedure, a fragment of DNA containing the natMX4 gene was PCR-amplified 
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from pAG25 (pVJ132) and integrated into the genome ofyeast strains VJY22 (hrdl!J), VJY102 
(doalO!J), VJY305 (hrdl !J doalO!J), and VJY97 (WT). Yeast strains used in this study are 
presented in Table 1. This fragment containing natMX4 was amplified with sequences 
homologous to sequence flanking the ASI3 gene and integrated into the yeast genome via 
homologous recombination. 
Amplification of the natMX4 gene was achieved via PCR from the pVJ132 plasmid. The 
primers VJR274 and VJR275 (See Table 2 for primer sequences) were used to amplify the 
natMX4 gene from the plasmid. The 5' ends ofthese primers have sequences ofnucleotides that 
are homologous (identical) to nucleotides in the yeast genome immediately upstream and 
downstream of the ASI3 gene coding sequence. These sequences will promote homologous 
recombination at the ASI3 locus, replacing that gene with the natMX4 gene. To generate the PCR 
fragment, the following ingredients were combined and separated into 50 f.!L aliquots: 20 11L of 
lOX ThermoPol buffer, 4 11L of 10 mM dNTPs, 4 11L ofpVJ132 miniprep, 1 11L of Taq 
polymerase, 4 11L of 50 mM pimer VJR 274, 41-!L of 50 mM primer VJR 275, and 163 11L of 
molecular biology grade water. PCR was performed using the following conditions: segment 1 
(1 cycle: 95°C for 5 minutes), segment 2 (35 cycles: 95°C for 30 seconds, 55°C for 30 seconds, 
and 72°C for 1 minute 30 seconds), segment 3 (1 cycle: 72°C for 10 minutes), and a final hold at 
1 0°C. 1 f.!L of the PCR product was separated on a 1% agarose gel, and the expected 1464 bp 
band was observed. The PCR fragment was column-purified using the Qiagen Gel Purification 
kit and the column purification protocol. 
To promote uptake of the PCR product into yeast cells and subsequent homologous 
recombination ofthe natMX4 gene at the ASI3 locus, a high-efficiency yeast transformation 
protocol was performed. The yeast strains VJY22, VJY102, VJY305, and VJY97 were first 
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grown on yeast extract peptone dextrose (YPD) agar plates, incubated overnight at 30°C, and 
then inoculated into 5 mL of YPD broth for overnight incubation at 30°C. The optical density at 
600 run (OD6oo) of the overnight cultures was determined, and the cultures were subsequently 
diluted to an OD6oo of0.2 in 50 mL ofYPD liquid. The samples were then placed in a shaker at 
30°C and allowed to reach mid-logarithmic growth phase (an OD6oo of approximately 1.0). Once 
this density was reached, the cells were centrifuged at 1,500 x g for seven minutes in a 50 mL 
conical tube. The supernatant was decanted, and the pellet was then resuspended in 25 mL of 
sterile water and centrifuged again under the same conditions. The supernatant was decanted. 
The cells were resuspended in 1 mL of 100 mM Lithium Acetate and transferred to a 1.5 mL 
microcentrifuge tube. This cell suspension was then centrifuged at 6,800 x g for two minutes, 
and the supernatant was removed by pi petting. 400 11L of 100 mM lithium acetate was added to 
the tube, and the cell pellet was again resuspended. The cells were suspended by vortexing, and 
100 11L of the suspension was ali quoted to a new microcentrifuge tube for each transformation. 
The suspension was centrifuged at 6,800 x g for two minutes, and the supernatant was removed 
by pipetting. 240 11L of 50% (w/v) polyethylene glycol, 36 11L of 1.0 M lithium acetate, and 20 
11L of freshly denatured (5 mg/mL) salmon sperm DNA were added to each transformation tube. 
Varying amounts ofPCR product (0 uL, 4 11L, or 40 11L) were added to individual transformation 
tubes. The samples were then mixed via pipetting and incubated in a 42°C water bath for 40 
minutes. The samples were centrifuged at 10,000 x g for 30 seconds, and the supernatant was 
removed via pipetting. 50 11L of sterile water was added to each tube, and the pellet was 
resuspended. Resuspended cells were plated onto YPD growth media. After one day of growth, 
the colonies were replica-plated onto YPD plates with nourseothricin (1 00 11g/mL) using sterile 
velvet sheets. 
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After four days of growth on the selective media, up to 16 candidates from each 
transformation were isolated for single colonies on YPD plates with nourseothricin and allowed 
to incubate overnight at 30°C. These candidates were then inoculated into 4 mL of YPD and 
were allowed to incubate overnight, rotating at 30°C. An untransformed parental control strain 
was also streaked and inoculated in parallel with the candidates. 
To screen for integration ofnatMX4 at the AS/3 locus, DNA was isolated from respective 
colonies of the transformed and parental control strains. 1 mL of saturated culture was 
transferred to a 2 mL screw-cap microcentrifuge tube and centrifuged at 2,700 x g for 2 minutes. 
The supernatant was removed, and 500 ~-tL of sterile water was added to each cell pellet. The 
pellet was resuspended and centrifuged using the same conditions. The supernatant was 
removed, and the cell pellets were resuspended in 200 ~-tL of Buffer A (2% Triton X-1 00, 1% 
sodium dodecyl sulfate, 100 mM NaCl, 10 mM Tris-HCl pH 8, 1 mM EDTA). Approximately 
200 ~-tL of acid washed glass beads were added to each tube, followed by the addition of 200 ~-tL 
ofphenol:chloroform:isoamyl alcohol (25:24:1) under a fume hood. The tubes were sealed with 
parafilm and agitated in an MP Biomedicals FastPrep-24 for 60 seconds at 5 meters/second at 
4 °C. Under the hood, the tubes were opened, 200 ~-tL of Buffer A was added, and the tubes were 
re-sealed with parafilm. After manually vortexing each tube for 1 0 seconds, the tubes were 
centrifuged for 5 minutes at 21,000 x g. Under a hood, 200 ~-tL ofthe aqueous layer (which 
contained the DNA) was transferred to a fresh 1.5 ml microcentrifuge tube. 1 mL of 95% ethanol 
was then added to each tube, and the DNA was allowed to precipitate overnight at -20°C. The 
samples were centrifuged for 10 minutes at 21,000 x gat 4°C, and the supernatant was removed 
via pi petting. The residual ethanol was allowed to evaporate out under a fume hood for 5 
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minutes. The pellet was resuspended in 25 f..!L ofTris-EDTA buffer (TE buffer; 10 mM Tris 
base, 0.5 mM EDTA, pH 8.0). 
Using this yeast genomic DNA, two sets ofPCR reactions were performed to confirm 
integration of natMX 4 at the ASI3 locus, one at the 5' end of the ASI3 locus and one at the 3' 
end. For the 5' PCR, each reaction mixture included 2.5 !lL of lOX ThermoPol buffer, 0.5 !lL of 
10 mM dNTPs, 0.5 !lL of primer VJR276, 10 f.lL of primer VJR277, 0.5 !lL of primer VJR246, 
0.125 !lL of Taq polymerase, and 19.875 !lL of molecular biology grade water. To each tube, 
0.05 !lL of the yeast genomic DNA was added, and PCR was performed using the following 
cycles: segment 1 (1 cycle: 95°C for 5 minutes), segment 2 (35 cycles: 95°C for 30 seconds, 
55°C for 30 seconds, and 72°C for 1 minute), segment 3 (1 cycle: 72°C for 10 minutes), and a 
final hold at 1 0°C. The PCR product was then separated on a 1% agarose gel. The expected 
product sizes were 820 bp (for cells harboring asi3L1::natMX4 mutation) or 649 bp (for cells 
harboring wild type AS/3). For the 3' PCR, each reaction tube included 2.5 !lL of lOX 
ThermoPol buffer, 0.5 !lL of 10 mM dNTPs, 0.5 !lL of primer VJR278, 0.5 !lL of primer 
VJR279, 0.5 !lL of primer VJR249, 0.125 !lL ofTaq polymerase, and 18.875 !lL of molecular 
biology grade water. To each tube, 0.05 f..!L of the yeast genomic DNA was added, and PCR was 
performed with the same cycles used for the 5' PCR reaction, described above. The PCR 
products were then separated on a 1% agarose gel. The expected product sizes were 808 bp (for 
cells harboring the asi3L1::natMX4 mutation) or 623 bp (for cells harboring wild type AS/3). 
Once the candidates had been confirmed using both 5' and 3' three-primer PCR, successful 
clones were stored at -80°C as glycerol permanent stocks by combining 500 !lL of 75% glycerol 
and 1 mL of culture. 
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Results 
Generation of plasmid encoding Degl-Sec62-Ura3:natMX4 
The protein Degl-Sec62-Ura3 (DSU) is a useful tool for the study ofthe ERAD-T 
pathway because the Ura3 component, linked to the C-terminus of the protein, will allow for 
selection of cells that exhibit differing abilities to perform ERAD-T. Cells that fail to degrade 
DSU will grow selectively in the absence of uracil, while cells that can degrade DSU will grow 
selectively in the presence of 5-FOA (Figure 3). This plasmid will be used in future experiments 
involving collections of yeast strains systematically lacking or overexpressing particular genes to 
identify those that work within the ERAD-T pathway. 
The creation of a plasmid containing Degl-Sec62-Ura3 and the natMX4 gene (which 
-
confers nourseothricin resistance) occurred through restriction enzyme-mediated subcloning, 
whereby a fragment containing the natMX4 gene was inserted downstream of the DSU gene. 
Using the restriction enzyme Eagl, the 1314 bp natMX4 fragment was isolated from a parental 
plasmid (pAG25/ pVJ132; Figure 4), and inserted into the Eagl-linearized 7673 bp DSU parental 
vector (p414-MET25-Degl-Sec62-Ura3/ pVJ132; Figure 5) that also contained the ampicillin 
resistance gene, ampR. The desired recombinant plasmid is illustrated in Figure 6. Digested 
plasmid fragments prepared to generate the recombinant DNA molecule were separated by 
agarose gel electrophoresis; the insert and vector fragments were gel-purified (Figure 7). 
Plasmids from eight candidate colonies were isolated and digested with the restriction enzyme 
Eagl to determine proper introduction of the natMX4 gene. Following Eagl digest, two of the 
plasmids exhibited DNA molecules of sizes consistent with the presence of both insert and 
vector fragments (7673 bp and 1314 bp; Eagl digest of parental plasmids and one successful 
clone is illustrated in Figure 8, lanes 1-3). Because only one enzyme was used to generate the 
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insert and vector fragments, the insert fragment could have been introduced in one of two 
orientations. Therefore, these plasmids were subsequently digested with Nco! to assess the 
orientation of the insert fragment (Figure 8, lanes 4-6). In both candidates, the insert displayed 
reverse orientation (that is, the natMX4 gene was transcribed from the opposite strand as DSU); 
the Neal-generated products were 5790, 1736, and 1461 bp. No candidates exhibited the insert in 
the same orientation as the DSU gene. Because the natMX4 gene was not designed to be in 
frame with the DSU gene, either orientation is acceptable for downstream applications. One 
candidate (Candidate #3) was preserved as the final recombinant plasmid. This plasmid (p414-
MET25-Degl-Sec62-Ura3_natMX4_jevori) was given the name pVJ519. 
Generation of asi3A::natMX4 strains 
The replacement of AS/3 (a gene encoding a subunit of the Asi ubiquitin ligase complex) 
with the natMX4 gene was achieved through PCR amplification ofnatMX4 from a plasmid 
(pAG25/ pVJ132; Figures 4 and 9); transformation of this PCR product into yeast strains VJY22 
(hrdlf).), VJY102 (doaJOI).), VJY305 (hrdlf). doalOI).), and VJY97 (WT); and subsequent 
integration via homologous recombination. The PCR product included DNA homologous to 
sequences upstream and downstream of the ASI3 gene; this encouraged recombination of 
natMX4 at the AS/3 locus. After transformation, the colonies were grown on media that 
contained nourseothricin to select for cells that possess the natMX4 gene. Correct integration of 
the natMX4 gene was assessed using two sets of three-primer PCR reactions. One reaction was 
performed at the 5' end of the integration site, and the other at the 3' end (Figures 10-12). In both 
PCR reactions, one primer in the set is homologous to DNA outside of the integration site, one 
primer is homologous to an internal sequence within the original ASI3 gene, and another is 
homologous to the new integrated sequence. When these PCR products are separated on an 
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agarose gel, band sizes vary depending on whether the natMX4 gene has integrated at the AS/3 
locus. Based on this analysis, the natMX4 gene was correctly inserted at the AS/3 locus in one of 
sixteen doal OLJ (VJY22) candidates, one of sixteen hrdl iJ (VJYl 02) candidates, two of sixteen 
doal Of::. hrdl!::.. (V JY305) candidates, and fifteen of sixteen WT (V JY97) candidates. Strains in 
which replacement of AS/3 with natMX4 was verified were preserved for future 
experimentation. 
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Discussion 
A plasmid containing the model ERAD-T substrate Degl-Sec62-Ura3 and the 
nourseothricin resistance gene natMX4 was created. This plasmid will be used in future 
experiments to determine proteins that work in both the ERAD-T and ER stress recovery 
pathways. Further, yeast strains lacking all combinations ofERAD and INMAD protein quality 
control ubiquitin ligases (DoalO, Hrd1, and Asi complex) were generated. These strains will be 
used to study the functions and interactions of the quality control pathways mediated by these 
enzymes. 
When the Doa10-dependent degron, Degl, was fused to the Sec62 transmembrane 
protein, Rubenstein et al. found that Hrd1 catalyzed its subsequent degradation [7]. The 
interaction between the protein Degl-Sec62 and the translocon allow for Hrd1 recognition. The 
protein apoB acts similarly when it is translocated into the ER membrane. It stalls within the 
translocon preceding LDL assembly, awaiting its lipid binding partner [18, 19]. If this protein 
does not interact with lipids and remains lodged in this channel, Hrd1 ubiquitylates it and 
catalyzes its destruction via the proteasome [7]. While this mechanism is not yet well 
understood, the protein Degl-Sec62 serves as a potential model for future study ofthis 
degradation mechanism. 
The accumulation of proteins within the lumen ofthe endoplasmic reticulum (also known 
as ER stress) is a cause of numerous etiologies [20]. Under ER stress conditions, the function of 
the ERAD-T pathway is limited. One hypothesis is that a protein (or multiple proteins) functions 
in both the ER stress response and ERAD-T. During ER stress, this protein may preferentially 
function to reduce the burden of misfolded proteins, limiting its availability to function in 
ERAD-T. If expressed at high levels, it is possible that this gene product could function in both 
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of these pathways, even under conditions of stress. Systematic overexpression of each gene of 
the yeast genome may yield a protein, or proteins, that can rescue the ERAD-T mechanism 
during ER stress. 
The Degl-Sec62-Ura3 protein will allow for a growth-based investigation ofERAD-T. In 
the presence ofthe compound 5-FOA, the Ura3 enzyme produces 5-FU. Under conditions ofER 
stress, Degl-Sec62-Ura3 is stabilized within the translocon, and yeast cells are unable to grow in 
the presence of 5-FOA (due to the generation of 5-FU). However, ifERAD-T is rescued by 
overexpression of a specific protein, cells will be able to grow because the Ura3-containing 
protein would be degraded through the ERAD-T pathway. Future work will be performed to 
identify genes that, when overexpressed, restore ERAD-T during ER stress. 
The ubiquitin ligase holoenzyme, Asi, is proposed to operate in a quality control pathway 
parallel to ERAD at the inner nuclear membrane [10] . Yeast strains with all combinations of 
knockouts of genes encoding the three ubiquitin ligases of the ER and inner nuclear membrane 
(DoalO, Hrd1, and Asi complex) will be useful tools in investigating the mechanisms, 
interactions, and substrates of these pathways. 
Highly conserved mechanisms of protein quality control are vital for cellular 
homeostasis. Here, tools were generated to study mechanisms of protein quality control in the 
model organismS. cerevisiae. Understanding these pathways could catalyze the development of 
therapeutic strategies for chronic medical conditions that are a result of ERAD or UPS 
malfunction, such as Alzheimer' s disease, cystic fibrosis, cholesterol-related pathology, and 
Parkinson's disease [16, 17]. 
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Figures and Tables 
Cytosol Nucleoplasm 
Lumen Lumen 
ERA D-C ERAD-M ERAD-L ERAD-T IN MAD 
Figure 1. Degradation of proteins at the ER and inner nuclear membrane. The E3 ubiquitin 
ligases DoalO, Hrdl , and Asi complex target proteins for degradation by the proteasome. DoalO 
catalyzes degradation of proteins with cytosolic degradation signals (ERAD-C substrates). Hrd 1 
catalyzes degradation of proteins with intramembrane and luminal degradation signals (ERAD-
M and ERAD-L substrates) and proteins that aberrantly or persistently engage the translocon 
(ERAD-T substrates). The Asi complex (Asi1 /Asi2/Asi3) catalyzes the degradation of inner 
nuclear membrane proteins. Yellow stars represent degradation signals. 
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ER stress 
Proteasome 
Figure 2. After aberrantly engaging the translocon, Degl-Sec62 becomes polyubiquitylated by 
Hrdl, a ubiquitin ligase, and Ubc7, a ubiquitin-conjugating enzyme. The protein is then sent to 
the proteasome for degradation. ER stress is an inhibitor of Hrd 1-dependent degradation of 
Degl-Sec62. 
24 
5-FOA 5-FU -·· ~ 
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Figure 3. Fusion ofthe Ura3 enzyme to the C-terminus of Degl-Sec62 allows for protein 
degradation to be monitored on the basis of cellular growth. Cells in which Degl-Sec62-Ura3 
protein is stabilized (e.g. cells lacking Hrdl or experiencing ER stress) are able to synthesize 
uracil or convert 5-FOA to the toxic compound 5-FU. Cells grow in the absence of uracil if the 
degradation pathway is impaired and survive in the presence of 5-FOA if the degradation 
pathway is intact. 
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Eagl (6) 
~ 
Eagl ( 1320) 
Figure 4. The plasmid pAG25 possesses the natMX4 gene. Restriction sites for the enzymes 
Nco! and Eagl are indicated. Digestion of this plasmid with Eagl yielded the insert fragment 
containing natMX4 for the generation of a plasmid containing both Degl-Sec62-Ura3 and 
natMX4. Amplification of the natMX4 gene by PCR provided the DNA used to replace the AS/3 
gene in strain construction experiments. 
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(5770) Eagl 
(4897) Nco! 
p414-M ET25-Deg 1-Sec62-Ura3 
7673 bp 
Nco! (3436) 
Figure 5. Following digestion with Eagl, the plasmid p414-MET25-Degl-Sec62-Ura3 served as 
the vector fragment for the generation of a plasmid containing both Degl-Sec62-Ura3 and 
natMX4. Restriction sites for the enzymes Nco! and Eagl are indicated. 
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(7084) Eagl 
p414-MET25-Deg 1-Sec62-Ura3_natMX4 
8987 bp 
(4897) Nco! 
Nco! (3436) 
Figure 6. Recombinant plasmid molecule possessing vector (p414-MET25-Degl-Sec62-Ura3) 
and insert (natMX4) fragments. Restriction sites for the enzymes Ncol and Eagl are indicated. 
28 
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8000 ::~ 3000~
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500 -
- -
;;;.-: 
-
-
-
-
1. pAG25 + Eagl 
2.None 
3. pAG25 (uncut) 
4. 1 kb DNA ladder 
-
5. p414-MET25-DSU (uncut) 
6. None 
7. p414-MET25-DSU + Eag/ 
Figure 7. Agarose gel electrophoresis ofthe insert (pAG25) and vector (p414-MET25-Degl-
Sec62-Ura3) fragments prepared by Eagl digestion (and phosphatase treatment of the vector) for 
generation of recombinant plasmid molecule. Undigested vector and insert plasmids were 
included as controls. Expected fragment sizes: pAG25, 2390 and 1314 bp; p414-MET25-Degl-
Sec62-Ura3, 7673 bp. The vector (7639 bp; Lane 7) and insert (1314 bp; Lane 1) fragments 
underwent gel purification and ligation. 
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bp 1 2 3 4 5 6 
-------
8000-
6000-
5000-
4000-
3000-
2000-
1500-
1000-
1. pAG25 + Eag/ 
2. p414-M ET25-DSU + Eag/ 
3. Clone #3 + Eagl 
4. pAG25 +Nco/ 
5. p414-MET25-DSU +Nco/ 
6. Clone #3 +Nco/ 
Figure 8. Agarose gel ofEagi and Ncol restriction digests to screen candidate recombinant 
p414-MET25-Degl-Sec62-Ura3_natMX4 plasmid molecules. Expected Eagl fragment sizes: 
p414-MET25-Degl-Sec62-Ura3 (parental vector plasmid), 7673 bp; pAG25 (parental insert 
plasmid), 2390 and 1314 bp; p414-MET25-Degl-Sec62-Ura3 _ natMX4 (recombinant plasmid), 
7673 and 1314 bp. Expected Ncol fragment sizes: p414-MET25-Degl-Sec62-Ura3 (parental 
vector plasmid), 6212 and 1461 bp; pAG25 (parental insert plasmid), 3704 bp; p414-MET25-
Degl-Sec62-Ura3_natMX4 (recombinant plasmid), 5790, 1736, and 1461 bp. Clone 3 is one 
successfully generated recombinant p414-MET25-Degl-Sec62-Ura3 _natMX4 plasmid. 
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bp 
-
1500-
1000-
Figure 9. Agarose gel electrophoresis of natMX4 PCR-amplified from pAG25 and gel-purified. 
Amplified natMX4 possesses flanking sequences homologous to sequences upstream and 
downstream of the ASI3 gene. The expected product size was 1464 bp. 
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5' 3' 
bp 1 2 3 4 5 6 7 8 9 10 11 12 13 14 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
-----------------------------'~-~ 
500- ···--11 · 
~~==========~ 
1. VJY 97 Candidate 1 
2. VJY 97 Candidate 2 
3. VJY 97 Candidate 3 
4. VJY 97 Candidate 4 
5. VJY 97 Candidate 5 
6. VJY 97 Candidate 6 
7. VJY 97 Candidate 7 
8. VJY 97 Candidate 8 
9. VJY 97 Candidate 9 
lO.VJY 97 Candidate 10 
11. VJY 97 Candidate 11 
12. VJY 97 Candidate 12 
13. VJY 97 Candidate 13 
14. VJY 97 Candidate 14 
Figure 10. Assessment ofnatMX4 integration into theASI3locus ofVJY97 via three-primer 
PCR. Left Panel: Three-primer PCR of the 5' end of insertion site. Expected sizes: 
asi3LI::natMX4, 820 bp; WT AS/3, 649 bp. Right Panel: Three-primer PCR ofthe 3' end of 
insertion site. Expected sizes: asi3LI::natMX4, 808 bp; WT AS/3, 623 bp. 
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VJY: 102 22 305 
---------bp 1 2 3 4 5 6 7 8 9 
----------
1000-
500--
1. VJY 102 Candidate 7 
2. VJY 102 Candidate 8 
3. VJY 102 Candidate 9 
4. VJY 22 Candidate 2 
5. VJY 22 Candidate 9 
- -
6. VJY 305 Candidate 6 
7. VJY 305 Candidate 7 
8. VJY 305 Candidate 8 
7. VJY 305 Candidate 9 
Figure 11. Assessment ofnatMX4 integration into the ASI3 locus ofVJY102, VJY22, and 
VJY305 via three-primer PCR at the 5' end of the insertion site. Expected sizes: asi3L1::natMX4, 
820 bp; WT ASI3, 649 bp. 
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VJY: 102 22 305 
-------bp 1 2 3 4 5 6 7 
--------
1000-
-
- -500 -
1. VJY 102 Candidate 7 6. VJY 305 Candidate 6 
2. VJY 102 Candidate 8 7. VJY 305 Candidate 9 
3. VJY 102 Candidate 9 
4. VJY 22 Candidate 2 
5. VJY 22 Candidate 9 
Figure 12. Assessment ofnatMX4 integration into the AS/3 locus ofVJY 102, VJY22, and 
VJY305 via three-primer PCR at the 3' end of the insertion site. Expected sizes: asi3L1::natMX4, 
808 bp; WT AS/3, 623 bp. 
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hrdl!J (HRDl knockout) 
Laboratory wild-type 
doalO!J (DOA10 knockout) 
hrdl!J doalO!J (HRDl and DOA10 knockout) 
asi3!J (AS/3 knockout) - 97 candidate# 2 
asi3!J (AS/3 knockout) - 97 candidate# 3 
hrdl!J asi3!J (HRDl andAS/3 knockout)- 22 
candidate # 9 
doalO!J asi3!J (DOA10 knockout) -102 
candidate # 8 
hrdl!J doalO!J asi3!J (HRDl, DOA10, and AS/3 
knockout)- 305 candidate #6 
hrdl!J doalO!J asi3!J (HRDl, DOA10, and AS/3 
kno - 305 candidate #9 
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ACCTCTGGCTGGAGGTCAC 
AGGAACAGTCATTACGTAGGGATTTTCAAAAGTTTGACTGCACATACGATTTAGGTGACAC 
TCCTATGATGTCTTAAATACGTATACCTAATAAAATAATTAATACGACTCACTATAGGGAG 
TCCAAACAATTGATGGCAGA 
TCAATGCTTGAAAAGAGTCCAA 
TGAACGCCTTCTGCATCATA 
TTTGGAAACTTACTAGAAAAGGCTA 
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